Atlas Trials

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Clinical trial NCT07168902 · COMPLETED

Trial details

NCT number
NCT07168902
Sponsor
Bausch & Lomb Incorporated
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glaucoma
Start date
2025-10-24
Primary completion
2026-05-18
Enrollment
252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.